Morath C - Search Results

1

Decreased NK cell immunity in kidney transplant recipients late post-transplant and increased NK-cell immunity in patients with recurrent miscarriage.

Zhu L, Aly M, Wang H, Karakizlis H, Weimer R, Morath C, Kuon RJ, Toth B, Opelz G, Daniel V. Zhu L, et al. Among authors: morath c. PLoS One. 2017 Oct 17;12(10):e0186349. doi: 10.1371/journal.pone.0186349. eCollection 2017. PLoS One. 2017. PMID: 29040297 Free PMC article.

2

Malignancy in renal transplantation.

Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Morath C, et al. J Am Soc Nephrol. 2004 Jun;15(6):1582-8. doi: 10.1097/01.asn.0000126194.77004.9b. J Am Soc Nephrol. 2004. PMID: 15153569 Review. No abstract available.

3

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.

Opelz G, Zeier M, Laux G, Morath C, Döhler B. Opelz G, et al. Among authors: morath c. J Am Soc Nephrol. 2006 Nov;17(11):3257-62. doi: 10.1681/ASN.2006050543. Epub 2006 Oct 11. J Am Soc Nephrol. 2006. PMID: 17035607

4

Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes.

Morath C, Zeier M, Döhler B, Schmidt J, Nawroth PP, Opelz G. Morath C, et al. J Am Soc Nephrol. 2008 Aug;19(8):1557-63. doi: 10.1681/ASN.2007070804. Epub 2008 May 21. J Am Soc Nephrol. 2008. PMID: 18495965 Free PMC article.

5

Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.

Beimler JH, Morath C, Schmidt J, Ovens J, Opelz G, Rahmel A, Zeier M, Süsal C. Beimler JH, et al. Among authors: morath c. Transplantation. 2009 Mar 15;87(5):668-71. doi: 10.1097/TP.0b013e318198a376. Transplantation. 2009. PMID: 19295310

6

Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft.

Morath C, Zeier M, Döhler B, Schmidt J, Nawroth PP, Schwenger V, Opelz G. Morath C, et al. Clin J Am Soc Nephrol. 2010 Mar;5(3):549-52. doi: 10.2215/CJN.03720609. Epub 2010 Jan 21. Clin J Am Soc Nephrol. 2010. PMID: 20093348 No abstract available.

7

An integrative approach for the transplantation of high-risk sensitized patients.

Morath C, Beimler J, Opelz G, Ovens J, Scherer S, Schmidt J, Schmied B, Gross ML, Schwenger V, Zeier M, Süsal C. Morath C, et al. Transplantation. 2010 Sep 27;90(6):645-53. doi: 10.1097/TP.0b013e3181ea3985. Transplantation. 2010. PMID: 20671598

8

Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch?

Morath C, Schmidt J, Opelz G, Zeier M, Süsal C. Morath C, et al. Langenbecks Arch Surg. 2011 Apr;396(4):467-74. doi: 10.1007/s00423-011-0759-x. Epub 2011 Mar 18. Langenbecks Arch Surg. 2011. PMID: 21416127 Review.

9

The role of pretransplant dialysis modality on renal allograft outcome.

Schwenger V, Döhler B, Morath C, Zeier M, Opelz G. Schwenger V, et al. Among authors: morath c. Nephrol Dial Transplant. 2011 Nov;26(11):3761-6. doi: 10.1093/ndt/gfr132. Epub 2011 Mar 22. Nephrol Dial Transplant. 2011. PMID: 21427080

10

Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy.

Morath C, Beimler J, Opelz G, Scherer S, Schmidt J, Macher-Goeppinger S, Klein K, Sommerer C, Schwenger V, Zeier M, Süsal C. Morath C, et al. Transpl Int. 2012 May;25(5):506-17. doi: 10.1111/j.1432-2277.2012.01447.x. Epub 2012 Feb 29. Transpl Int. 2012. PMID: 22372718 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters